BCM
WVE icon

Burrage Capital Management’s Wave Life Sciences WVE Stock Holding History

Burrage Capital Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-56,699
Closed -$556K – 29
2020
Q1 		$556K Sell
56,699
-49,287
-47% -$420K 0.55% 28
2019
Q4 		$849K Buy
+105,986
New +$2.6M 0.57% 24

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Burrage Capital Management's WVE Position: Q2 2020 in Review

Burrage Capital Management sold out of Wave Life Sciences (WVE) in Q2 2020, closing a stake of 56,699 shares — an estimated $556K sold.

Burrage Capital Management first reported a position in WVE in Q4 2019 and held it in 2 quarters. The position peaked at $849K in Q4 2019. 91 funds tracked by Wall St. Rank hold WVE as of Q2 2020.

  • Burrage Capital Management reported no remaining Wave Life Sciences position as of Q2 2020 after selling out during the quarter.
  • Burrage Capital Management sold 56,699 Wave Life Sciences shares in Q2 2020, an estimated $556K.
  • Burrage Capital Management first reported a position in Wave Life Sciences in Q4 2019 and held it in 2 quarters.
  • Burrage Capital Management's Wave Life Sciences position peaked at $849K in Q4 2019.
  • 91 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2020.

Based on Burrage Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.